Objective: Due to a gap between published clinical guidelines on status epilepticus SE and clinician management of SE, a systematic review was performed to investigate treatment adherence to SE guidelines and its impact on patient outcomes. Methods: Medline and Embase searches were conducted for studies appraising adherence to SE guidelines (from 1970 and 1st April 2018). The quality of eligible studies was assessed by QUADAS-2 criteria. Comparison was made between patients where guidelines were followed and not followed. Various patient outcomes including intubation, ICU admission, morbidity and mortality were compared. A Forest plot was used to investigate the effect of adherence on outcome. Results: A total of 3424 titles and abstracts were screened from the initial search after removal of duplicates. A total of 441 full text articles were reviewed in detail, and 22 articles were included in this study. The proportion of deviations ranged from 10.7% to 66.1%. Four studies were descriptive. Eighteen studies looked at the adverse effects of non-adherence. Eight studies showed respiratory depression and intubation were associated with excessive benzodiazepine use. A subset analysis showed 5.79 times higher odds of respiratory depression and intubation], if excessive benzodiazepines were given. The next most common variations were delayed management and insufficient treatment. These variations from the guidelines were associated with prolonged seizures. Conclusions: This review provides preliminary evidence that non-adherence to SE guidelines negatively impacts on patient outcomes. Appropriate and timely treatment is imperative for rapid seizure termination and improving outcomes.
Introduction
Status epilepticus (SE) is a common neurological emergency with significant morbidity and mortality [1, 2] . There is a gap between evidence based best management and actual clinical practice [3] .To decrease this gap, clinical practice guidelines(CPGs), based on available evidence are employed [4] [5] [6] [7] . It is unclear if the available guidelines for SE have any impact on patient outcomes.
Guidelines are systematically developed algorithms to assist clinical decision-making [8] . Guidelines for the management of SE have been available for many years, yet a number of retrospective studies have confirmed that clinicians often do not follow recommended guidelines on the management of patients with SE [1, 4, 9, 10] . Common deviations from guidelines include delay in administration of anticonvulsants and excessive benzodiazepine use [11] .
The prognosis of SE is related to many factors e.g. age, aetiology, history of prior seizures and type of seizure at SE onset [12] . Several studies have evaluated the effect of adherence to treatment guidelines [2, 4, [13] [14] [15] and these studies have given conflicting results. However, adherence to guidelines has not been subject to systematic review previously. There has recently been a review published looking at the state of epilepsy practice guidelines [16] , however, the implementation of guidelines continues to be uncertain [17] .
This study aims to conduct a systematic review investigating adherence to SE clinical practice guidelines and its impact on patient morbidity including respiratory depression and ICU admission.
Methods

Search strategy
This systematic review was performed according to the PRISMA guidelines [18] (Fig. 1 ). Medline and EMBASE databases were searched for articles published between 1 January 1970 and 1 April 2018, investigating the adherence to SE treatment guidelines.
Identification
The following text and MeSH terms were used in our search: (seizures/or status epilepticus and (guideline adherence/or guideline/or clinical protocols or practice guideline) and (deviation from guidelines.mp or benzodiazepines/ad,ae,to or anticonvulsant/ad, ae,to) and (intubation or ICU admission or length of stay or morbidity or mortality or treatment outcome). See detailed search strategy, e-1. The language was limited to English. Only human studies were included.
The review question was broken down to help guide the development of search terms using the PICO structure. Possible synonyms and abbreviations for the terms of interest and subject headings (including MeSH headers) were included.
Inclusion criteria
1) All patients: with SE, seizure duration > 5 min 2) Adult and paediatric studies (age >28 days)
Exclusion criteria
1) Personal views and letters to editors 2) Studies with incomplete data 3) Conference abstracts
The Medline and Embase searches identified 3773 articles (Fig. 1 ). Bibliographic references of the studies were also searched. Scopus was hand searched to find relevant and highly cited papers in this area. We hand searched the first authors of included papers to find articles that may not have been appropriately indexed but were relevant to the questions. A total of 67 additional records identified through these searches.
The authors have not included unpublished abstracts and other grey literature as the data is often incomplete and non-peer reviewed.
Screening
A total of 3424 records were screened after removal of 416 duplicates (Fig. 1) . We screened titles and abstracts and excluded all irrelevant publications. If the paper was deemed relevant by any of the authors or the relevance was not clear from the title and abstract, then the full text was retrieved.
Eligibility
A total of 441 full-text articles were reviewed and 419 articles excluded; of these 233 were comparisons between medications and/or compared various routes of administration; 83 were opinions, review articles and letters to the editor; 77 were guidelines or comments on guidelines; 14 articles had duplicate or incomplete data; 10 were expert commentaries and 2 were physician perspectives.
Study quality
For quality assessment, a template based on Quality Assessment of Diagnostic Accuracy Studies tool (QUADAS-2) [19] was used.
Results
The search strategy identified 22 articles, which were included in the systematic review. Included studies were appraised for their risk of bias and applicability ( Fig. 2a & b) . The quality assessment was used for evaluative purposes. No studies were excluded based on quality assessment.
Studies included
There were 22 studies included in the review (Fig. 1) . Four articles described non-adherence to guidelines [11, [20] [21] [22] . Eighteen studies also looked at the effect of non-adherence on various patient outcomes and morbidity including respiratory depression, intubation and ICU admission [1, 2, 4, 9, 10, [13] [14] [15] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] . This review did not investigate individual drug comparisons and nor did we look at impact of the route of administration.
Characteristics of the target population and studies
The definition of SE varied between studies. Eleven of the 22 included studies have used the classical definition of seizure duration >30 min (Table 1 ). Five out of the 22 studies have used the operational definition of SE to include >5 min of seizure activity [33] . Two studies used >15 min [25, 26] , two studies used failure of >2 antiepileptic drugs [11, 32, 34] , one used the inclusion criteria of witnessed seizures and receiving at least one anticonvulsant [29] and another used the chief complaint of seizure in emergency department as the inclusion criteria [20] . Thirteen paediatric studies [1, [9] [10] [11] 13, 14, 22, [24] [25] [26] 29, 30, 32] , eight adult studies [2, 4, 15, 20, 23, 27, 28, 31] , and one study with both paediatric and adult populations [21] were included ( Table 1) .
The SE clinical practice guidelines followed by all the various studies used similar first and second line anticonvulsant recommendations. The first line agent was always a benzodiazepine (BZD) e.g. lorazepam or midazolam and the second line was a long acting anticonvulsant e.g. phenytoin. However, there were slight variations in the guidelines. In two studies, levetiracetam [11, 23] and in another two studies valproate [23, 28] was considered as appropriate second line treatments along with phenytoin. In four studies, intramuscular fosphenytoin was the second line agent [4, 11, 14, 24] .
Seven studies were prospective [1, 10, 11, 13, 23, 31, 32] , twelve were retrospective [4, 9, 14, 20, 22, [24] [25] [26] [27] [28] [29] [30] and in three, data was extracted from a prospectively collected database [2, 15, 21] . There Paediatric Studies Gaínza-Lein, et al. [32] 2018 N = 218 Prospective Failure of >2 AEDS Hospital Fernandez, et al. [11] 2015 N = 81 Prospective Failure of >2 AEDS Hospital Shatirishvili, et al. [13] 2014 N = 48 Prospective >30 min Hospital Tirupathi, et al. [14] 2009 N = 47 Retrospective >30 min Tertiary Hospital/ICU Tobias, et al. [10] 2008 N = 100 Prospective >30 min ICU Chin, et al. [1] 2008 N = 182 Prospective >30 min Population Eriksson, et al. [24] 2005 N = 184 Retrospective >5 min ED/Paed ICU Chin, et al. [9] 2004 N = 91 Retrospective >30 min Paed ICU Kwong, et al. [22] 2004 N = 25 Retrospective >30 min Paed ICU Eriksson et al. [25] 1997 N = 65 Retrospective >15 min Paed ICU Alldredge, et al. [26] 1995 N = 38 Retrospective >15 min Hospital Chiulli, et al. [30] 1994 N = 146 Retrospective >30 min ED Orr, et al. [29] 1991 N = 98 Retrospective Witnessed seizure+ 1 AED Hospital
Adult Studies
Rosetti, et al. [15] 2013 N = 263 Prospective registry >5 min Hospital Spatola, et al. [2] 2013 Adults Prospective registry >5 min Hospital N = 202 Aranda, et al. [31] 2010 N = 111 Prospective >5 min Population Martin-Gill, et al. [20] 2009 N = 87 Retrospective Acute seizure Prehospital & ED Rossetti, et al. [23] 2009 N = 54 Prospective >5 min Peripheral/Central Hosp. Muayqil, et al. [4] 2007 N = 45 Retrospective >30 min Emergency Martinet al. [28] 1995 N = 43 Retrospective >30 min Hospital Scholtes, et al. [27] 1994 Fig. 3 ).
Adherence to SE guidelines
Rates of adherence were reported in all the 22 included studies. The proportion of deviations ranged from 10.7% [27] to 66.1% [32] . In a recent multicentre, prospective study of 218 patients in the United States 66.1% patients received the first line benzodiazepines 10 min or more after the seizure onset [32] . In a prospective study of 111 adults [31] from France the odds of seizure termination with first-line treatment was 11 times greater if the protocol was adhered to (Fig. 3) [31] . Similarly, a retrospective study of 47 children in Ireland [14] reported a non-adherence rate of 53.2% and the odds of ICU admission were 3.1 times higher if there was non-adherence to the protocol (Fig. 3) . A Swiss study of 263 adults reported that adherence to treatment guidelines had no effect on morbidity, mortality or likelihood of seizure control [15] .
Excessive benzodiazepine use [1, 2, 9, 13, 14] was the most commonly reported reason for non-adherence, followed by delayed management [1, 4, 11, 15, 32] , insufficient treatment [27, 31] , prehospital treatment [38] and location of treatment i.e. large academic vs. peripheral hospital [23] .
The data from studies was summarized in the form of a forest box-plot (see Fig. 3 ) where odds ratios could be calculated. These results suggest there are higher odds of adverse outcome for most deviations from guidelines. Worse outcomes were seen in both paediatric [1, 9, 13, 14, 26] and adult studies [2, 15, 27, 31] .
Effect of excessive benzodiazepines (BZDs)
Benzodiazepines are a widely recognized first-line treatment for SE, but may also be associated with respiratory depression [35] . Of the 22 studies, eight [1, 2, [9] [10] [11] 13, 14, 30] reported excessive BZD use. For excessive benzodiazepines, the pooled OR (Fig. 3) shows much higher odds (OR = 5.79) for adverse outcomes including respiratory depression, intubation and ICU admission [1, 2, 9, 13, 14] . A recent prospective observational study at nine tertiary paediatric hospitals in the USA [11] , showed 39.7% (31/78) received at least three doses of benzodiazepines prior to escalation to non-benzodiazepine medications. An American study done prospectively in paediatric ICU patients, found respiratory compromise was more common in patients who received a BZD dose greater than recommended guidelines [10] . A Table 2 Studies describing the deviation from protocol (%) and the effect of deviation on the patient outcomes (if measured).
Study (By year)
Year paediatric emergency department study in New York looked at type of benzodiazepine and intubation rates. This study reported that diazepam use resulted in a higher number of intubations as compared to lorazepam [30] . The New York study demonstrated 12 out of 26 patients required endotracheal intubation that the authors considered was related to excessive BZD administration [30] .
A prospective study investigated BZD over dosage in SE and its relationship with the need for intubation and length of hospitalization [2] . It compared 173 adult patients who received standard BZD doses to those receiving excessive doses (>30% above recommended dose, n = 29) and quantitated the morbidity and mortality. The study found a statistically significant increase in the intubation rate with 45% (13/29) of the "excessive" BZD patients intubated for airway protection, versus only 8% (13/173) where the BZD dose was appropriate (p < .001) (Box plot1). A Georgian paediatric study found that 13/17 patients who received excessive BZDs required to be intubated [13] . None of the 31 patients who received appropriate BZD required intubation (p < .049) [13] .
A paediatric study of 47 children, found three times higher odds of excessive benzodiazepines in the children with convulsive SE admitted to intensive care, when compared to the ward group [14] . Two other studies found higher odds of respiratory depression [9] and respiratory insufficiency [1] when excessive BZDs were given. For excessive benzodiazepine use, the pooled OR shows much higher odds (OR = 5.79) for adverse outcomes including respiratory depression, intubation and ICU admission.
Delay in initiation of treatment of SE
Five out of 22 studies examined if there was a delay in initiation of treatment. These include delay in pre-hospital treatment, delay in arrival to emergency department, or delay in administration of first and second line antiepileptic agent. In a recent multicentre, prospective study 66.1% patients received the first line benzodiazepines 10 min or more after the seizure onset [32] . The multivariate analysis showed these patients higher odds of death after adjusting for confounders (adjusted odds ratio, 11.0), In another study, treatment was initiated after an hour following the onset of SE in 62/225 patients [15] . A delay in presentation to the emergency department was associated with a longer duration of seizure. For a delay in treatment of every minute from onset of SE, there was a 5% increase in the risk of the episode being longer lasting, in excess of 60 min [1] . A recent In a retrospective study of 45 adults, delayed management was associated with significantly longer seizure duration (median: 95 versus 38 min); compared to where management was instituted in the recommended timeframes (p 0.02) [4] .
Effect of pre-hospital treatment
Two studies showed that the initiation of SE therapy frequently started pre-hospital [26, 31] . One study described up to 64% of the patients received pre-hospital treatment [31] . Pre-hospital therapy of SE with diazepam decreased the duration of SE [26] . It also reduced the risk of recurrent seizures in the hospital [26] . Fig. 3 . Forest plot -the odds ratios (95%CI), of adverse outcomes due to non-adherence to treatment guidelines. With non-adherence, these results suggest there are higher odds of adverse outcome for most deviations from guidelines. For excessive benzodiazepines in particular, the pooled OR shows much higher odds for adverse outcomes (OR = 5.79).
Effect of insufficient treatment
Only one study looked at insufficient treatment [27] . The criteria for insufficient treatment included the doses administered were too low, wrong route of administration was used, or a delay to move on to the next line of treatment. Of the 346 patients (15years) of SE looked at retrospectively "insufficient" treatment was found in 22.5% in patients who had negative sequelae. In patients with good outcome, insufficient treatment was seen in only 8% [27] . Treatment was deemed to be insufficient in the 17 of the 38 patients (44%) who died [27] .
Effect of hospital setting
There was a single study looking at hospital setting and adherence to guidelines [23] . It was a prospective study comparing management and prognosis of SE according to the academic tertiary versus peripheral hospital setting, done in Switzerland [23] . The treatment in 22% of patients in peripheral hospitals was not in accordance the guidelines as compared to 3% in Centre Hospital, p = .04 [23] . There was no significant difference in the patient outcomes [23] .
Discussion
This systematic review is the first to investigate the effect of clinician adherence to SE clinical practice guidelines and its impact on patients. Although there are clinical practice guidelines for SE, it is clear from this systematic review that SE clinical practice guidelines are not being followed. All of the studies in this systematic review confirmed the management of status epilepticus varied from the clinical practice guidelines. Non-adherence to SE management guidelines were associated with an increased chance of worse outcome including ICU admission [14] and mortality [32] .
Adherence to the treatment guidelines is associated with faster seizure termination and better seizure control [31] . The systematic review found that most studies violated the guidelines and the main protocol deviations were excessive benzodiazepine use and delay to treatment [11] . An excessive use of benzodiazepines is related to higher odds of respiratory depression and intubation. (Fig. 3) .
Appropriate and timely treatment is imperative for early seizure termination [31] . Comparisons between medications and/ or various routes of administration were not examined in this systematic review. For example important randomized controlled trials such as RAMPART [36] which looked at route of administration of benzodiazepines could not be included in the review. RAMPART [36] found that IM midazolam is no different to IV lorazepam for the management of SE. Intramuscular administration can be given more rapidly than IV administration but this was not felt to be an important contributor to guideline violations and was not examined. This systematic review included both adult and paediatric age groups. Our study shows that there was deviation from guidelines seen in both paediatric studies [1, [9] [10] [11] 13, 14, 22, [24] [25] [26] 29, 30, 32] , adult studies [2, 4, 15, 20, 23, 27, 28, 31] , and a study with both paediatric and adult populations [21] . The included studies were mostly emergency department and ICU based studies and did not look at if the diagnosis or initiation of treatment was made in consultation with a specialist neurologist. The guidelines are designed to enable early initiation of treatment and seeking speciality consultation may delay this.
This systematic review is not without limitations. This systematic review did not include unpublished data, abstracts from conferences and clinician personal communications. Lowlevel evidence studies have not been included in this review.
Twelve of the 22 included studies are retrospective studies [4, 9, 14, 20, 22, [24] [25] [26] [27] [28] [29] [30] . Various studies have chosen different inclusion criteria for status epilepticus (Table 1) and different outcome measures (Table 2) . We were unable to conduct a meta-analysis due to the heterogeneity of the included studies.
The need to understand why clinicians do not follow SE clinical practice guidelines is paramount. One of the outstanding characteristics of our current health care systems is the gap between what should be done and what is delivered [37] . It is commonly known that guidelines are not translated into clinical practice [38] . The barriers in one setting may be different from another [38] . This review would form the basis for quality improvement in the management of status epilepticus, to understand and improve the factors responsible for non-adherence to guidelines.
Conclusions
Implementation of SE guidelines may improve management. To provide maximum benefit to the patients, it is imperative that appropriate care is instituted for patients presenting with a seizure. This review highlights that deviations from guidelines exist and have been studied to some extent. The adverse effect of non-compliance and its impact on patient care has not been vigorously and systematically studied. This review provides evidence that non-adherence to SE guidelines leads to adverse outcomes. Most of the studies consistently showed adverse outcomes were related to the use of excess benzodiazepines.
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